Anpac Bio Medical Science Co Ltd (ANPC) Stock

DelistedNasdaq: ANPCFresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China.

3.80
Final close · Jul 21, 2023

ANPC is no longer traded. Anpac Bio Medical Science was delisted from the Nasdaq in July 2023.

Prices on this page are historical; the last trade was July 21, 2023 at $3.80.

Anpac Bio Medical Science stock price history

Split-adjusted closes, 2020–2023

ANPC final trading statistics

Final close
$3.80
Final trading day
Jul 21, 2023
Market cap at delisting
$23.84M
Shares outstanding
6.27M
Final 52-week range
$0.13 – $11.99
Avg. volume (final 3 mo.)
16,834
All-time high (split-adj.)
$2250.00 · Jan 2020
All-time low (split-adj.)
$28.00 · Sep 2022
Return since IPO
-98.3%
Beta
1.56
Book value / share
$10.63
Price / book
0.36
Final 52 wk
0.1311.99

Anpac Bio Medical Science earnings per share

Earnings per share

Anpac Bio Medical Science revenue & net income

RevenueNet income

Anpac Bio Medical Science annual financials

Anpac Bio Medical Science Co Ltd revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2022$12.04M-$103.6M—
FY2021$17.99M-$120.1M—
FY2020$20.51M-$80.6M—
FY2019$10.85M-$101.6M-$1.29
FY2018$10.25M-$42.1M-$0.47

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Anpac Bio Medical Science Co Ltd

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is headquartered in Shanghai, the People's Republic of China.

Anpac Bio Medical Science stock FAQ

What happened to Anpac Bio Medical Science stock?

Anpac Bio Medical Science stock was delisted from the Nasdaq. Its final close was $3.80 on July 21, 2023.

Is ANPC stock still trading?

No. ANPC was delisted from the Nasdaq in July 2023 and no longer trades on a U.S. exchange.

What was the last price of ANPC stock?

ANPC closed at $3.80 on its final trading day, July 21, 2023, for a market value of about $23.84M.

What were Anpac Bio Medical Science's revenue and earnings in its last full fiscal year?

Anpac Bio Medical Science reported revenue of $12.04M and net income of -$103.6M in fiscal 2022, its last full year as a public company.

When did Anpac Bio Medical Science go public?

Anpac Bio Medical Science Co Ltd stock began trading on January 30, 2020.

Biotechnology stocks to research

All Healthcare stocks →